Point Capital, Inc. (35) | Uncategorized (6)

Recent Contracts

Sublicense Agreement, dated April 6, 2021, by and between the Company and AIkido Pharma, Inc (Filed With SEC on April 7, 2021)
Description of the Registrants Securities (Filed With SEC on March 29, 2021)
Letter of Intent, dated February 12, 2021, by and between the Company and Aikido Pharma, Inc (Filed With SEC on February 16, 2021)
Form of Lock-Up Agreement, dated as of February 9, 2021 (Filed With SEC on February 10, 2021)
Sponsored Research Agreement by and between the Company and the University of Maryland, Baltimore (Filed With SEC on January 11, 2021)
Form of Lock-Up Agreement, dated as of April 28, 2020 (Filed With SEC on April 29, 2020)